Home Business Qianjin Pharmaceutical’s performance report: 2021 net profit of 302 million yuan, a year-on-year increase of 1.62% – Teller Report

Qianjin Pharmaceutical’s performance report: 2021 net profit of 302 million yuan, a year-on-year increase of 1.62% – Teller Report

by admin
</p> <p> Qianjin Pharmaceutical’s performance report: 2021 net profit of 302 million yuan, a year-on-year increase of 1.62% – Teller Report<br /> news.google.com/__i/rss/rd/articles/images/public.css” />news.google.com/__i/rss/rd/articles/images/share_style0_16.css” />

news.google.com/__i/rss/rd/articles/images/css1.css” rel=”stylesheet” type=”text/css” />

Home > News > e company

Qianjin Pharmaceutical’s performance report: net profit of 302 million yuan in 2021, a year-on-year increase of 1.62%

2022-01-14 18:07

Source: Securities Times e Company

Author: Xu Qingtianmei

Securities Times · e company

Xu Qingtianmei

2022-01-14 18:07

Securities Times e Company News, Qianjin Pharmaceutical (600479) released a performance report on the evening of January 14. Its operating income in 2021 will be 3.665 billion yuan, a year-on-year increase of 1.06%; the net profit attributable to the parent is 302 million yuan, a year-on-year increase of 1.62%; The stock income was 0.72 yuan.

Disclaimer: Securities Times strives for true and accurate information. The content mentioned in the article is for reference only and does not constitute substantive investment advice. Operational risks are based on this.

  • Securities Times APP
  • WeChat public account


  • 4074747

    Qianjin Pharmaceutical’s performance report: net profit of 302 million yuan in 2021, a year-on-year increase of 1.62%

    6885

    e company

    news

    1445

    Xu Qingtianmei

    2022-01-14

    0 comment
    0

    You may also like

    Leave a Comment

    This site uses Akismet to reduce spam. Learn how your comment data is processed.

    This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

    Privacy & Cookies Policy